Help guide our efforts to modernize
Send us your comments by March 14, 2020. Menu

Hair Cortisol and Testosterone in Heart Failure

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01139697
Recruitment Status : Completed
First Posted : June 8, 2010
Last Update Posted : May 16, 2012
Information provided by (Responsible Party):
Meir Medical Center

Brief Summary:
The purpose of this study is to determine whether hair cortisol and testosterone levels correlate with heart failure status in patient with chronic congestive heart failure.

Condition or disease Intervention/treatment
Systolic Heart Failure Other: Hair sampling

Detailed Description:

Progression of chronic congestive heart failure (CHF) is associated with abnormal secretion of several hormones including glucocorticoids and testosterone.

A single study of patients with chronic heart failure has demonstrated that higher serum levels of cortisol are independent predictors of increased mortality risk. However, this study included patients with heart failure who were admitted to the hospital due to other causes and it might be speculated that the single serum cortisol measurement taken may have been influenced by the acute illness or by the emotional stress associated with the admission itself.

Currently, there are several modalities for measuring cortisol levels including serum, urinary and salivary techniques. However, all these methods represent indicators of acute cortisol secretion and do not reflect accumulation of the hormone over time. Recently there has been a growing interest in measuring hair cortisol level. Hair grows approximately 1 centimeter per month and therefore hair analysis accurately reflects long-term endogenous production of cortisol. This provides for the first time a reliable mode for the measurement of the accumulation of cortisol over time. We have recently demonstrated higher hair cortisol levels in patients with acute myocardial infarction compared with controls (the manuscript has been submitted for publication). Regarding testosterone, several studies have recently demonstrated lower free serum testosterone levels in patients with heart failure compared with controls. Furthermore, Serum testosterone levels were inversely correlated with heart failure status.

The longitudinal assessment of cortisol and testosterone levels over time using the hair technique may be superior to a single random serum sample for the assessment of chronic heart failure status and prognosis.

If indeed, hair cortisol and testosterone levels would correlate with heart failure status, they may be used as a quantitative mode for clinical follow-up of CHF patients (similar to the role of HbA1C in the follow-up of diabetic patients). However this hypothesis has not yet been evaluated

Layout table for study information
Study Type : Observational
Actual Enrollment : 46 participants
Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Hair Cortisol and Testosterone Levels and Their Correlation With Heart Failure Status in Patients With Chronic Congestive Heart Failure
Study Start Date : August 2010

Group/Cohort Intervention/treatment
Patients with systolic heart failure
Patients with systolic heart failure defined as ejection fraction <45%
Other: Hair sampling
Hair sampling for the measurement of cortisol and testosterone

Primary Outcome Measures :
  1. Correlation of hair cortisol and testosterone with heart failure status [ Time Frame: One year ]

    Ccorrelation of hair cortisol and testosterone with clinical and laboratory parameters that their correlation with heart failure status is well established including:

    1. Ejection fraction as assessed by echo-doppler.
    2. Physical capacity as assessed by stress test.
    3. Serum levels of hs-CRP, NT-proBNP. 4)1 year mortality

    5)hospital admissions after 6 and 12 months

Secondary Outcome Measures :
  1. Mortality [ Time Frame: 6 and 12 months ]
    The association of hair cortisol and testosterone with mortality

  2. Hospital adMissions [ Time Frame: 6 and 12 months ]
    The correlation of hair cortisol and testosterone with hospital admission

Biospecimen Retention:   Samples Without DNA
Hair samples for the measurment of cortisol and testosterone

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   Male
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients with systolic heart failure from the out-patient clinic at the Meir Medical Center

Inclusion Criteria:

  • Males
  • Age >18
  • Left ventricular (LV) systolic function (EF<45 per echocardiography)

Exclusion Criteria:

  • Any corticosteroid treatment in the last 6 months
  • Any treatment with testosterone in the last 6 months
  • Diagnosis or Cushing's or Addison's disease
  • Any hospital admission within 3 months prior to enrollment
  • Inability to sign inform consent
  • Patients with moderate or severe aortic stenosis
  • Inability to provide 3 cm hair sample from vertex posterior.
  • Dyed hair
  • Morbid obesity (BMI>35)
  • Any symptomatic chronic lung disease

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01139697

Layout table for location information
Meir Medical Center
Kfar Saba, Israel, 44281
Sponsors and Collaborators
Meir Medical Center
Layout table for investigator information
Principal Investigator: David Pereg, MD Cardiology department, Meir Medical Center
Principal Investigator: Morris Mosseri, MD Cardiology departement, Meir medical Center

Layout table for additonal information
Responsible Party: Meir Medical Center Identifier: NCT01139697    
Other Study ID Numbers: cortest-chf-1
First Posted: June 8, 2010    Key Record Dates
Last Update Posted: May 16, 2012
Last Verified: May 2012
Keywords provided by Meir Medical Center:
Heart failure
Additional relevant MeSH terms:
Layout table for MeSH terms
Heart Failure
Heart Failure, Systolic
Heart Diseases
Cardiovascular Diseases
Hydrocortisone 17-butyrate 21-propionate
Hydrocortisone acetate
Hydrocortisone hemisuccinate
Testosterone undecanoate
Testosterone enanthate
Testosterone 17 beta-cypionate
Hormones, Hormone Substitutes, and Hormone Antagonists
Physiological Effects of Drugs
Antineoplastic Agents, Hormonal
Antineoplastic Agents
Anabolic Agents
Anti-Inflammatory Agents